The post-COVID face of pharma research and development
The acute phase of the COVID-19 pandemic not only brought delays, restrictions, and reconfigurations to pharmaceutical research & development in 2020, but also a more flexible response to some long-standing issues with the clinical trials process. Lockdown rules and safety protocols certainly made it harder for patients to travel to trial sites, while a refocusing […]